Edwards Lifesciences Corp. (EW) Tops Q4 EPS by 13c; Guides Q1, FY13

February 4, 2013 4:02 PM EST Send to a Friend
Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.90, $0.13 better than the analyst estimate of $0.77. Revenue for the quarter came in at $510.5 million versus the consensus estimate of $499.46 million.

Edwards Lifesciences Corp. sees FY2013 EPS of $3.21-3.31, versus the consensus of $3.27. Edwards Lifesciences Corp. sees FY2013 revenue of $2.1-2.2 billion, versus the consensus of $2.14 billion.

Edwards Lifesciences Corp. sees Q1 2013 EPS of $0.74-0.78, versus the consensus of $0.77. Edwards Lifesciences Corp. sees Q1 2013 revenue of $505-530 million, versus the consensus of $517.7 million.

For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings

Comments

error in next quater number
tomguest on 2013-02-04 16:20:55
Mark as Spam | Reply to this comment

how could it be 317m? should be 517m


Add Your Comment